Description
A derivative of lycorine with antihypertensive and neuroprotective activities; inhibits methoxamine-induced contraction of isolated rabbit aortic rings and rat anococcygeus muscle (pA2s = 5.93 and 6.35, respectively); reduces MAP in anesthetized and conscious normotensive rats at 80 mg/kg; reduces electrically or phenylephrine-induced hypertension in pithed rats; reduces infarct size, cerebral edema, and myeloperoxidase activity in a rat model of focal cerebral ischemia-reperfusion injury when administered following reperfusion
Formal name: (1S,2S,3aR,12bS,12cR)-2,3,3a,4,5,7,12b,12c-octahydro-1H-[1,3]dioxolo[4,5-j]pyrrolo[3,2,1-de]phenanthridine-1,2-diol
Synonyms:
Molecular weight: 289.3
CAS: 6271-21-2
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Ox Stress Reagents|Antioxidants||Research Area|Cardiovascular System|Cardiovascular Diseases|Hypertension||Research Area|Cardiovascular System|Cardiovascular Diseases|Stroke||Research Area|Cardiovascular System|Vasculature|Vasodilation||Research Area|Neuroscience|Neuroprotection|Ischemia||Research Area|Oxidative Stress & Reactive Species|Antioxidant Activity||Research Area|Oxidative Stress & Reactive Species|Reactive Oxygen|Myeloperoxidase